EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension

Florent Soubrier and colleagues identify biallelic mutations in EIF2AK4 as a major cause of pulmonary veno-occlusive disease, a rare form of pulmonary hypertension. EIF2AK4 encodes a serine-threonine kinase, and the disease-causing mutations are predicted to result in loss of protein function. Pulmo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Nature genetics Ročník 46; číslo 1; s. 65 - 69
Hlavní autoři: Eyries, Mélanie, Montani, David, Girerd, Barbara, Perret, Claire, Leroy, Anne, Lonjou, Christine, Chelghoum, Nadjim, Coulet, Florence, Bonnet, Damien, Dorfmüller, Peter, Fadel, Elie, Sitbon, Olivier, Simonneau, Gérald, Tregouët, David-Alexandre, Humbert, Marc, Soubrier, Florent
Médium: Journal Article
Jazyk:angličtina
Vydáno: New York Nature Publishing Group US 01.01.2014
Nature Publishing Group
Témata:
ISSN:1061-4036, 1546-1718, 1546-1718
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Florent Soubrier and colleagues identify biallelic mutations in EIF2AK4 as a major cause of pulmonary veno-occlusive disease, a rare form of pulmonary hypertension. EIF2AK4 encodes a serine-threonine kinase, and the disease-causing mutations are predicted to result in loss of protein function. Pulmonary veno-occlusive disease (PVOD) is a rare and devastating cause of pulmonary hypertension that is characterized histologically by widespread fibrous intimal proliferation of septal veins and preseptal venules and is frequently associated with pulmonary capillary dilatation and proliferation 1 , 2 . PVOD is categorized into a separate pulmonary arterial hypertension–related group in the current classification of pulmonary hypertension 3 . PVOD presents either sporadically or as familial cases with a seemingly recessive mode of transmission 4 . Using whole-exome sequencing, we detected recessive mutations in EIF2AK4 (also called GCN2 ) that cosegregated with PVOD in all 13 families studied. We also found biallelic EIF2AK4 mutations in 5 of 20 histologically confirmed sporadic cases of PVOD. All mutations, either in a homozygous or compound-heterozygous state, disrupted the function of the gene. These findings point to EIF2AK4 as the major gene that is linked to PVOD development and contribute toward an understanding of the complex genetic architecture of pulmonary hypertension.
Bibliografie:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:1061-4036
1546-1718
1546-1718
DOI:10.1038/ng.2844